Levobupivacaine
CAS: 27262-47-1
Ref. TM-T1787
5mg | 52.00 € | ||
10mg | 67.00 € | ||
25mg | 96.00 € | ||
50mg | 138.00 € | ||
100mg | 190.00 € | ||
200mg | 278.00 € | ||
500mg | 476.00 € | ||
1ml*10 (DMSO) | 49.00 € |
Product Information
- (-)-(S)-Bupivacaine
- (-)-Bupivacaine
- (2S)-1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
- (2S)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
- 2',6'-Pipecoloxylidide, 1-butyl-, (-)-
- 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (S)-
- 2′,6′-Pipecoloxylidide, 1-butyl-, (-)-
- <span class="text-smallcaps">L</span>-(-)-Bupivacaine
- Chirocain
- L-(-)-Bupivacaine
- See more synonyms
Levobupivacaine is an amino-amide local anaesthetic drug belonging to the family of n-alkylsubstituted pipecoloxylidide. It is the S-enantiomer of bupivacaine. Levobupivacaine hydrochloride is commonly marketed by AstraZeneca under the trade name Chirocaine. Compared to bupivacaine, levobupivacaine is associated with less vasodilation and has a longer duration of action. It is approximately 13 per cent less potent (by molarity) than racemic bupivacaine.Levobupivacaine is indicated for local anaesthesia including infiltration, nerve block, ophthalmic, epidural and intrathecal anaesthesia in adults; and infiltration analgesia in children. Adverse drug reactions (ADRs) are rare when it is administered correctly. Most ADRs relate to administration technique (resulting in systemic exposure) or pharmacological effects of anesthesia, however allergic reactions can rarely occur.
Chemical properties
Technical inquiry about: TM-T1787 Levobupivacaine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.